Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Nandini Mondal, PhD, Mariana Silva, PhD, Ana Castano, MD, Marcela V. Maus, MD PhD, Robert Sackstein, MD PhD

Blood (2018) 132 (Supplement 1): 2056.

https://doi.org/10.1182/blood-2018-99-118675

Published: 2018

Journal Articles

Fucosyltransferase VI Induces Platelet Activation: A Novel Property of a Plasma Glycosyltransferase.

José-Tomás Navarro, MD, Shwan Tawfiq, MD, Roland Wohlgemuth, Karin M. Hoffmeister, MD, Robert Sackstein, MD, PhD

Blood (2009) 114 (22): 4016.

https://doi.org/10.1182/blood.V114.22.4016.4016

Published: 2009

Journal Articles

Ex Vivo Glycan Engineering of Membrane CD44 To Create HCELL Programs Human Mesenchymal Stem Cell Trafficking to Bone.

Robert Sackstein, MD, PhD, Jasmeen S. Merzaban, PhD, Derek W. Cain, Nilesh M. Dagia, PhD, Joel A. Spencer, Charles P. Lin, PhD, Roland Wohlgemuth, PhD

Blood (2007) 110 (11): 218.

https://doi.org/10.1182/blood.V110.11.218.218

Published: 2007

Journal Articles

CD15 (Lewis x) Expression in Human Myeloid Cell Differentiation Is Regulated by Sialidase Activity.

Samah Z. Gadhoum, PhD, Robert Sackstein, MD, PhD

Blood (2006) 108 (11): 1931.

https://doi.org/10.1182/blood.V108.11.1931.1931

Published: 2006

Journal Articles

HCELL Is the Major E- and L-Selectin Ligand Expressed on Human Hematopoietic Progenitor Cells and Colon Carcinoma Cells.

Julia T. Chu, BS, Monica M. Burdick, PhD, Robert Sackstein, MD,PhD

Blood (2006) 108 (11): 4177.

https://doi.org/10.1182/blood.V108.11.4177.4177

Published: 2006

Journal Articles

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

David T. Ting, MD, Bimalangshu Dey, MD, Ahmed Chaudhary, Christine Colby, Karen Power, Steven McAfee, MD, Karen Ballen, MD, Eyal Attar, MD, Susan Saidman, Frederick Preffer, Robert Sackstein, MD, PhD, Juanita Shaffer, Megan Sykes, MD, Thomas R. Spitzer, MD

Blood (2005) 106 (11): 3665.

https://doi.org/10.1182/blood.V106.11.3665.3665

Published: 2005

NARROW

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Fucosyltransferase VI Induces Platelet Activation: A Novel Property of a Plasma Glycosyltransferase.

Ex Vivo Glycan Engineering of Membrane CD44 To Create HCELL Programs Human Mesenchymal Stem Cell Trafficking to Bone.

CD15 (Lewis x) Expression in Human Myeloid Cell Differentiation Is Regulated by Sialidase Activity.

HCELL Is the Major E- and L-Selectin Ligand Expressed on Human Hematopoietic Progenitor Cells and Colon Carcinoma Cells.

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

Overcoming a Critical Obstacle Towards Effective and Safe CAR T-Cell Therapeutics

Fucosyltransferase VI Induces Platelet Activation: A Novel Property of a Plasma Glycosyltransferase.

Ex Vivo Glycan Engineering of Membrane CD44 To Create HCELL Programs Human Mesenchymal Stem Cell Trafficking to Bone.

CD15 (Lewis x) Expression in Human Myeloid Cell Differentiation Is Regulated by Sialidase Activity.

HCELL Is the Major E- and L-Selectin Ligand Expressed on Human Hematopoietic Progenitor Cells and Colon Carcinoma Cells.

Development of Late over Early Full Donor Chimerism (FDC) Results in Improved Progression-Free and Overall Survival in Patients with Advanced Malignant Lymphomas Receiving Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only